BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6157523)

  • 1. Binding to R 1881 (methyltrienolone) of proteins from human benign prostatic hypertrophy.
    Kodama T; Hasebe C; Shimazaki J
    Endocrinol Jpn; 1980 Apr; 27(2):229-37. PubMed ID: 6157523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the androgen-binding proteins in human benign prostatic hypertrophy].
    Tomioka O
    Hinyokika Kiyo; 1983 Mar; 29(3):267-85. PubMed ID: 6203381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin-binding protein in human benign prostatic hypertrophy.
    Kodama T; Ito M; Sato R; Ito H; Shimazaki J
    Endocrinol Jpn; 1981 Apr; 28(2):175-85. PubMed ID: 6171422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by various steroids on dihydrotestosterone binding to androphilic protein in human benign prostatic hypertrophy.
    Kodama T; Honda S; Shimazaki J
    Endocrinol Jpn; 1978 Oct; 25(5):453-60. PubMed ID: 84756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of dihydrotestosterone, R 1881 and R 5020 in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Nozumi K; Sato R; Ito H; Maruoka M; Shimazaki J
    Urol Int; 1981; 36(2):79-87. PubMed ID: 6169181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of androgen binding sites by exchange with methyltrienolone (R 1881).
    Bonne C; Raynaud JP
    Steroids; 1976 Apr; 27(4):497-507. PubMed ID: 58452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of androphilic proteins in cytosols of human benign prostatic hypertrophy.
    Kodama T; Shimazaki J
    Endocrinol Jpn; 1979 Aug; 26(4):449-58. PubMed ID: 91507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the androgen binding in human benign prostatic hypertrophy.
    Nijs M; Coune A
    J Recept Res; 1989; 9(3):271-95. PubMed ID: 2475625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial characterization of [3H]methyltrienolone binding in rat prostate cytosol.
    Pousette A; Snochowski M; Bression D; Högberg B; Gustafsson JA
    Biochim Biophys Acta; 1979 Jan; 582(2):358-67. PubMed ID: 760830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of chlormadinone acetate to cytosol from human benign prostatic hypertrophy.
    Kodama T; Wakisaka M; Shimazaki J
    Endocrinol Jpn; 1980 Feb; 27(1):53-7. PubMed ID: 6156069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of progestin-binding protein in benign hypertrophic human prostate.
    Akimoto S; Sato R; Kodama T; Zama S; Fuse H; Shimazaki J
    Endocrinol Jpn; 1986 Jun; 33(3):423-32. PubMed ID: 2428606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
    Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
    J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androphilic proteins in cytosols of human benign prostatic hypertrophy.
    Kodama T; Honda S; Shimazaki J
    Endocrinol Jpn; 1977 Dec; 24(6):565-73. PubMed ID: 75101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
    Schwemmer B; Böttger I; Schiessl J; Reidel G; Schütz W
    Urol Int; 1986; 41(2):133-8. PubMed ID: 2425471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-binding proteins in human benign prostatic hypertrophy.
    Rosen V; Jung I; Baulieu EE; Robel P
    J Clin Endocrinol Metab; 1975 Oct; 41(4):761-70. PubMed ID: 51854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.
    Akimoto S; Fuse H; Sato R; Zama S; Shimazaki J
    Endocrinol Jpn; 1985 Feb; 32(1):141-52. PubMed ID: 2410244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androphilic proteins in the human prostate.
    Shimazaki J; Ito H; Kodama T; Nozumi K; Maruoka M; Wakisaka M; Naito H; Miyauchi T; Matsumura T; Sato R
    Prostate Suppl; 1981; 1():9-17. PubMed ID: 6176984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 16 beta-ethyl-17 beta-hydroxy-4-estren-3-one (TSAA-291) on the binding of promegestone (R5020) and methyltrienolone (R1881) to hyperplastic and neoplastic human prostate.
    Bashirelahi N; Ganesan S; Ekiko DB; Young JD; Shida K; Yamanaka H; Takahashi E
    J Steroid Biochem; 1986 Sep; 25(3):367-74. PubMed ID: 2430141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.